Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

CT-996

Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

Carmot Australia First Pty Ltd · Phase 1 · Completed · Enrollment 94

NCT05814107

ArmPopulationDoseWeeksEstimandWeight change
Part 1: CT-996 SAD Cohort 1Obesity + T2Dn/rn/rn/rn/r
Part 1: CT-996 SAD Cohort 2Obesity + T2Dn/rn/rn/rn/r
Part 1: CT-996 SAD Cohort 3, Then SAD Cohort 5Obesity + T2Dn/rn/rn/rn/r
Part 1: CT-996 SAD Cohort 4Obesity + T2Dn/rn/rn/rn/r
Part 1: CT-996 SAD Cohort 6Obesity + T2Dn/rn/rn/rn/r
Part 1: Placebo SAD CohortObesity + T2Dn/rn/rn/rn/r
Part 2: CT-996 MAD Cohort 1Obesity + T2Dn/rn/rn/rn/r
Part 2: CT-996 MAD Cohort 2Obesity + T2Dn/rn/rn/rn/r
Part 2: CT-996 MAD Cohort 3Obesity + T2Dn/rn/rn/rn/r
Part 2: Placebo MAD CohortObesity + T2Dn/rn/rn/rn/r
Part 3: CT-996 MD T2DM Cohort 1Obesity + T2Dn/rn/rn/rn/r
Part 3: CT-996 MD T2DM Cohort 2Obesity + T2Dn/rn/rn/rn/r
Part 3: Placebo MD T2DM CohortObesity + T2Dn/rn/rn/rn/r